What liver side effects have been reported with ezetimibe?
Ezetimibe can cause elevations in liver-related blood tests, especially increases in serum transaminases (aminotransferases). These lab changes can, in some cases, be accompanied by symptoms that suggest liver inflammation or injury. Reported liver-related reactions include:[1]
- Increased alanine aminotransferase (ALT) and/or aspartate aminotransferase (AST)
- Hepatitis (inflammation of the liver)
- Elevations in bilirubin
- Rare reports of more serious liver injury, including cholestasis (reduced bile flow) and liver failure
When do liver problems usually show up?
The exact timing is not consistent across reports, but drug-related liver test abnormalities can occur during treatment and are typically detected through routine or symptom-triggered blood work. Clinicians often check liver tests if a patient develops symptoms suggestive of liver injury or if there are risk factors or concurrent liver-stressing therapies.[1]
Who is at higher risk?
Risk can be higher if ezetimibe is used with other medications that can also affect the liver—most notably statins (for example, in combination therapy). Liver test abnormalities are specifically a concern when ezetimibe is taken together with statins, because both drugs can influence liver enzymes.[1]
What symptoms should prompt medical attention?
Symptoms that can be associated with liver injury include:[1]
- Yellowing of the skin or eyes (jaundice)
- Dark urine
- Fatigue that is out of proportion or persistent nausea/vomiting
- Right upper abdominal discomfort or pain
- Unexplained itching
- Loss of appetite
If these occur while taking ezetimibe, patients should contact a clinician promptly for liver test evaluation.
What happens if liver enzymes rise while taking ezetimibe?
If liver enzymes increase, clinicians may:
- Recheck liver tests to confirm the pattern and degree of change
- Review other liver-affecting medicines (especially statins) and alcohol use
- Consider holding or stopping ezetimibe if abnormalities are significant or associated with symptoms, then monitor recovery
The specific action depends on how high the enzymes/bilirubin rise and whether symptoms are present.[1]
How does this compare with statins?
Statins are more commonly linked with liver enzyme elevations than ezetimibe. However, ezetimibe can still contribute—particularly when combined with statins—so clinicians monitor liver tests in that setting.[1]
Source used
[1] https://www.drugs.com/monograph/ezetimibe.html